作者
Javier Bolaños‐Meade,Mehdi Hamadani,Juan Wu,Monzr M. Al Malki,Michael Märtens,Lyndsey Runaas,Hany Elmariah,Andrew R. Rezvani,Mahasweta Gooptu,Karilyn Larkin,Brian C. Shaffer,Najla El Jurdi,Alison W. Loren,Melhem Solh,Aric C. Hall,Amin M. Alousi,Omer Jamy,Miguel‐Angel Perales,Janny M. Yao,Kristy Applegate,Ami S. Bhatt,Leslie S. Kean,Yvonne A. Efebera,Ran Reshef,W. B. Clark,Nancy DiFronzo,Eric Leifer,Mary M. Horowitz,Richard J. Jones,Shernan G. Holtan
摘要
In patients undergoing allogeneic hematopoietic stem-cell transplantation (HSCT), a calcineurin inhibitor plus methotrexate has been a standard prophylaxis against graft-versus-host disease (GVHD). A phase 2 study indicated the potential superiority of a post-transplantation regimen of cyclophosphamide, tacrolimus, and mycophenolate mofetil.
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
嘻嘻哈哈
Copyright
zzzz
美满的访旋
超帅的忆曼
Alex_T
OK
YifanWang
Oracle
Sure
ye
迷人的天抒
无情的聪健
ucas
贪玩的秋柔
bbr
Nole
Criminology34
MchemG
皖公网安备34019202002308
